Skip to main content
Erschienen in: Der Internist 1/2019

17.12.2018 | Typ-2-Diabetes | CME

Ernährung bei Diabetes mellitus Typ 2

verfasst von: Dr. S. Brede, Prof. Dr. H. Lehnert

Erschienen in: Die Innere Medizin | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die zunehmende Inzidenz metabolischer Erkrankungen, wie des Diabetes mellitus Typ 2, ist ein gesundheitsökonomisches Problem. Ernährungsmaßnahmen stellen eine therapeutische Grundlage zur Verhinderung gesundheitlicher Konsequenzen, beispielsweise kardiovaskulärer Erkrankungen, dar. Nach aktueller Datenlage werden diese weniger durch einzelne Nahrungsbestandteile als vielmehr durch die Zusammensetzung der Nahrung bestimmt. Für verschiedene Ernährungsformen ist eine positive Beeinflussung des Glukose- und Fettstoffwechsels bei Typ-2-Diabetes nachgewiesen. Neben der Ernährungsart ist aber auch die blutzuckersteigernde Wirkung, der sogenannte glykämische Index von Lebensmitteln, entscheidend. Zudem konnten für verschiedene Lebensmittel, unter anderem für Kaffee, positive Effekte bei Patienten mit Diabetes nachgewiesen werden.
Literatur
2.
Zurück zum Zitat Brede S, Serfling G, Klement J et al (2016) Clinical scenario of the metabolic syndrome. Visc Med 32:336–341CrossRef Brede S, Serfling G, Klement J et al (2016) Clinical scenario of the metabolic syndrome. Visc Med 32:336–341CrossRef
3.
Zurück zum Zitat Riccardi G, Rivellese AA, Giacco R (2008) Role of glycemic index and glycemic load in the healthy state, in prediabetes, and in diabetes. Am J Clin Nutr 87:269S–274SCrossRef Riccardi G, Rivellese AA, Giacco R (2008) Role of glycemic index and glycemic load in the healthy state, in prediabetes, and in diabetes. Am J Clin Nutr 87:269S–274SCrossRef
4.
Zurück zum Zitat Foster-Powell K, Holt SH, Brand-Miller JC (2002) International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr 76:5–56CrossRef Foster-Powell K, Holt SH, Brand-Miller JC (2002) International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr 76:5–56CrossRef
5.
Zurück zum Zitat Gomes JMG, Fabrini SP, Alfenas RCG (2017) Low glycemic index diet reduces body fat and attenuates inflammatory and metabolic responses in patients with type 2 diabetes. Arch Endocrinol Metab 61:137–144CrossRef Gomes JMG, Fabrini SP, Alfenas RCG (2017) Low glycemic index diet reduces body fat and attenuates inflammatory and metabolic responses in patients with type 2 diabetes. Arch Endocrinol Metab 61:137–144CrossRef
7.
Zurück zum Zitat Pi-Sunyer X (2005) Do glycemic index, glycemic load, and fiber play a role in insulin sensitivity, disposition index, and type 2 diabetes? Diabetes Care 28:2978–2979CrossRef Pi-Sunyer X (2005) Do glycemic index, glycemic load, and fiber play a role in insulin sensitivity, disposition index, and type 2 diabetes? Diabetes Care 28:2978–2979CrossRef
8.
Zurück zum Zitat Soare A, Khazrai YM, Del Toro R et al (2014) The effect of the macrobiotic Ma-Pi 2 diet vs. the recommended diet in the management of type 2 diabetes: the randomized controlled MADIAB trial. Nutr Metab (Lond) 11:39CrossRef Soare A, Khazrai YM, Del Toro R et al (2014) The effect of the macrobiotic Ma-Pi 2 diet vs. the recommended diet in the management of type 2 diabetes: the randomized controlled MADIAB trial. Nutr Metab (Lond) 11:39CrossRef
9.
Zurück zum Zitat Silva FM, Kramer CK, De Almeida JC et al (2013) Fiber intake and glycemic control in patients with type 2 diabetes mellitus: a systematic review with meta-analysis of randomized controlled trials. Nutr Rev 71:790–801CrossRef Silva FM, Kramer CK, De Almeida JC et al (2013) Fiber intake and glycemic control in patients with type 2 diabetes mellitus: a systematic review with meta-analysis of randomized controlled trials. Nutr Rev 71:790–801CrossRef
10.
Zurück zum Zitat Flaim C, Kob M, Di Pierro AM et al (2017) Effects of a whey protein supplementation on oxidative stress, body composition and glucose metabolism among overweight people affected by diabetes mellitus or impaired fasting glucose: a pilot study. J Nutr Biochem 50:95–102CrossRef Flaim C, Kob M, Di Pierro AM et al (2017) Effects of a whey protein supplementation on oxidative stress, body composition and glucose metabolism among overweight people affected by diabetes mellitus or impaired fasting glucose: a pilot study. J Nutr Biochem 50:95–102CrossRef
11.
Zurück zum Zitat Archundia Herrera MC, Subhan FB, Chan CB (2017) Dietary patterns and cardiovascular disease risk in people with type 2 diabetes. Curr Obes Rep 6:405–413CrossRef Archundia Herrera MC, Subhan FB, Chan CB (2017) Dietary patterns and cardiovascular disease risk in people with type 2 diabetes. Curr Obes Rep 6:405–413CrossRef
12.
Zurück zum Zitat Anania C, Perla FM, Olivero F et al (2018) Mediterranean diet and nonalcoholic fatty liver disease. World J Gastroenterol 24:2083–2094CrossRef Anania C, Perla FM, Olivero F et al (2018) Mediterranean diet and nonalcoholic fatty liver disease. World J Gastroenterol 24:2083–2094CrossRef
13.
Zurück zum Zitat Faria A, Persaud SJ (2017) Cardiac oxidative stress in diabetes: mechanisms and therapeutic potential. Pharmacol Ther 172:50–62CrossRef Faria A, Persaud SJ (2017) Cardiac oxidative stress in diabetes: mechanisms and therapeutic potential. Pharmacol Ther 172:50–62CrossRef
14.
Zurück zum Zitat Lau WB, Ohashi K, Wang Y et al (2017) Role of adipokines in cardiovascular disease. Circ J 81:920–928CrossRef Lau WB, Ohashi K, Wang Y et al (2017) Role of adipokines in cardiovascular disease. Circ J 81:920–928CrossRef
15.
Zurück zum Zitat Holvoet P, Lee DH, Steffes M et al (2008) Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. JAMA 299:2287–2293CrossRef Holvoet P, Lee DH, Steffes M et al (2008) Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. JAMA 299:2287–2293CrossRef
16.
Zurück zum Zitat Tsai IJ, Croft KD, Mori TA et al (2009) 20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction. Free Radic Biol Med 46:263–270CrossRef Tsai IJ, Croft KD, Mori TA et al (2009) 20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction. Free Radic Biol Med 46:263–270CrossRef
17.
Zurück zum Zitat Bullo M, Lamuela-Raventos R, Salas-Salvado J (2011) Mediterranean diet and oxidation: nuts and olive oil as important sources of fat and antioxidants. Curr Top Med Chem 11:1797–1810CrossRef Bullo M, Lamuela-Raventos R, Salas-Salvado J (2011) Mediterranean diet and oxidation: nuts and olive oil as important sources of fat and antioxidants. Curr Top Med Chem 11:1797–1810CrossRef
18.
Zurück zum Zitat Carluccio MA, Siculella L, Ancora MA et al (2003) Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals. Arterioscler Thromb Vasc Biol 23:622–629CrossRef Carluccio MA, Siculella L, Ancora MA et al (2003) Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals. Arterioscler Thromb Vasc Biol 23:622–629CrossRef
19.
Zurück zum Zitat Papoutsi Z, Kassi E, Chinou I et al (2008) Walnut extract (Juglans regia L.) and its component ellagic acid exhibit anti-inflammatory activity in human aorta endothelial cells and osteoblastic activity in the cell line KS483. Br J Nutr 99:715–722CrossRef Papoutsi Z, Kassi E, Chinou I et al (2008) Walnut extract (Juglans regia L.) and its component ellagic acid exhibit anti-inflammatory activity in human aorta endothelial cells and osteoblastic activity in the cell line KS483. Br J Nutr 99:715–722CrossRef
20.
Zurück zum Zitat Mitjavila MT, Fandos M, Salas-Salvado J et al (2013) The Mediterranean diet improves the systemic lipid and DNA oxidative damage in metabolic syndrome individuals. A randomized, controlled, trial. Clin Nutr 32:172–178CrossRef Mitjavila MT, Fandos M, Salas-Salvado J et al (2013) The Mediterranean diet improves the systemic lipid and DNA oxidative damage in metabolic syndrome individuals. A randomized, controlled, trial. Clin Nutr 32:172–178CrossRef
21.
Zurück zum Zitat Salas-Salvado J, Bullo M, Babio N et al (2011) Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care 34:14–19CrossRef Salas-Salvado J, Bullo M, Babio N et al (2011) Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care 34:14–19CrossRef
22.
Zurück zum Zitat Dominguez LJ, Bes-Rastrollo M, De La Fuente-Arrillaga C et al (2013) Similar prediction of total mortality, diabetes incidence and cardiovascular events using relative- and absolute-component Mediterranean diet score: the SUN cohort. Nutr Metab Cardiovasc Dis 23:451–458CrossRef Dominguez LJ, Bes-Rastrollo M, De La Fuente-Arrillaga C et al (2013) Similar prediction of total mortality, diabetes incidence and cardiovascular events using relative- and absolute-component Mediterranean diet score: the SUN cohort. Nutr Metab Cardiovasc Dis 23:451–458CrossRef
23.
Zurück zum Zitat Estruch R, Ros E, Martinez-Gonzalez MA (2013) Mediterranean diet for primary prevention of cardiovascular disease. N Engl J Med 369:676–677PubMed Estruch R, Ros E, Martinez-Gonzalez MA (2013) Mediterranean diet for primary prevention of cardiovascular disease. N Engl J Med 369:676–677PubMed
24.
Zurück zum Zitat Diaz-Lopez A, Babio N, Martinez-Gonzalez MA et al (2015) Mediterranean diet, retinopathy, nephropathy, and microvascular diabetes complications: a post hoc analysis of a randomized trial. Diabetes Care 38:2134–2141CrossRef Diaz-Lopez A, Babio N, Martinez-Gonzalez MA et al (2015) Mediterranean diet, retinopathy, nephropathy, and microvascular diabetes complications: a post hoc analysis of a randomized trial. Diabetes Care 38:2134–2141CrossRef
25.
Zurück zum Zitat Bozzetto L, Prinster A, Annuzzi G et al (2012) Liver fat is reduced by an isoenergetic MUFA diet in a controlled randomized study in type 2 diabetic patients. Diabetes Care 35:1429–1435CrossRef Bozzetto L, Prinster A, Annuzzi G et al (2012) Liver fat is reduced by an isoenergetic MUFA diet in a controlled randomized study in type 2 diabetic patients. Diabetes Care 35:1429–1435CrossRef
27.
Zurück zum Zitat Veum VL, Laupsa-Borge J, Eng O et al (2017) Visceral adiposity and metabolic syndrome after very high-fat and low-fat isocaloric diets: a randomized controlled trial. Am J Clin Nutr 105:85–99CrossRef Veum VL, Laupsa-Borge J, Eng O et al (2017) Visceral adiposity and metabolic syndrome after very high-fat and low-fat isocaloric diets: a randomized controlled trial. Am J Clin Nutr 105:85–99CrossRef
28.
Zurück zum Zitat Guldbrand H, Dizdar B, Bunjaku B et al (2012) In type 2 diabetes, randomisation to advice to follow a low-carbohydrate diet transiently improves glycaemic control compared with advice to follow a low-fat diet producing a similar weight loss. Diabetologia 55:2118–2127CrossRef Guldbrand H, Dizdar B, Bunjaku B et al (2012) In type 2 diabetes, randomisation to advice to follow a low-carbohydrate diet transiently improves glycaemic control compared with advice to follow a low-fat diet producing a similar weight loss. Diabetologia 55:2118–2127CrossRef
29.
Zurück zum Zitat Westman EC, Yancy WS Jr., Mavropoulos JC et al (2008) The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus. Nutr Metab (Lond) 5:36CrossRef Westman EC, Yancy WS Jr., Mavropoulos JC et al (2008) The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus. Nutr Metab (Lond) 5:36CrossRef
30.
Zurück zum Zitat Hallberg SJ, Mckenzie AL, Williams PT et al (2018) Effectiveness and safety of a novel care model for the management of type 2 diabetes at 1 year: an open-label, non-randomized, controlled study. Diabetes Ther 9:583–612PubMedPubMedCentral Hallberg SJ, Mckenzie AL, Williams PT et al (2018) Effectiveness and safety of a novel care model for the management of type 2 diabetes at 1 year: an open-label, non-randomized, controlled study. Diabetes Ther 9:583–612PubMedPubMedCentral
31.
Zurück zum Zitat Seidelmann SB, Claggett B, Cheng S et al (2018) Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis. Lancet Public Health 3:e419–e428CrossRef Seidelmann SB, Claggett B, Cheng S et al (2018) Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis. Lancet Public Health 3:e419–e428CrossRef
32.
Zurück zum Zitat Brouns F (2018) Overweight and diabetes prevention: is a low-carbohydrate-high-fat diet recommendable? Eur J Nutr 57:1301–1312CrossRef Brouns F (2018) Overweight and diabetes prevention: is a low-carbohydrate-high-fat diet recommendable? Eur J Nutr 57:1301–1312CrossRef
33.
Zurück zum Zitat Dong JY, Zhang ZL, Wang PY et al (2013) Effects of high-protein diets on body weight, glycaemic control, blood lipids and blood pressure in type 2 diabetes: meta-analysis of randomised controlled trials. Br J Nutr 110:781–789CrossRef Dong JY, Zhang ZL, Wang PY et al (2013) Effects of high-protein diets on body weight, glycaemic control, blood lipids and blood pressure in type 2 diabetes: meta-analysis of randomised controlled trials. Br J Nutr 110:781–789CrossRef
34.
Zurück zum Zitat Tay J, Thompson CH, Luscombe-Marsh ND et al (2015) Long-term effects of a very low carbohydrate compared with a high carbohydrate diet on renal function in individuals with type 2 diabetes: a randomized trial. Medicine (Baltimore) 94:e2181CrossRef Tay J, Thompson CH, Luscombe-Marsh ND et al (2015) Long-term effects of a very low carbohydrate compared with a high carbohydrate diet on renal function in individuals with type 2 diabetes: a randomized trial. Medicine (Baltimore) 94:e2181CrossRef
35.
Zurück zum Zitat Krebs JD, Elley CR, Parry-Strong A et al (2012) The Diabetes Excess Weight Loss (DEWL) Trial: a randomised controlled trial of high-protein versus high-carbohydrate diets over 2 years in type 2 diabetes. Diabetologia 55:905–914CrossRef Krebs JD, Elley CR, Parry-Strong A et al (2012) The Diabetes Excess Weight Loss (DEWL) Trial: a randomised controlled trial of high-protein versus high-carbohydrate diets over 2 years in type 2 diabetes. Diabetologia 55:905–914CrossRef
36.
Zurück zum Zitat Dinu M, Abbate R, Gensini GF et al (2017) Vegetarian, vegan diets and multiple health outcomes: a systematic review with meta-analysis of observational studies. Crit Rev Food Sci Nutr 57:3640–3649CrossRef Dinu M, Abbate R, Gensini GF et al (2017) Vegetarian, vegan diets and multiple health outcomes: a systematic review with meta-analysis of observational studies. Crit Rev Food Sci Nutr 57:3640–3649CrossRef
37.
Zurück zum Zitat Appel LJ, Brands MW, Daniels SR et al (2006) Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension 47:296–308CrossRef Appel LJ, Brands MW, Daniels SR et al (2006) Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension 47:296–308CrossRef
38.
Zurück zum Zitat Siervo M, Lara J, Chowdhury S et al (2015) Effects of the Dietary Approach to Stop Hypertension (DASH) diet on cardiovascular risk factors: a systematic review and meta-analysis. Br J Nutr 113:1–15CrossRef Siervo M, Lara J, Chowdhury S et al (2015) Effects of the Dietary Approach to Stop Hypertension (DASH) diet on cardiovascular risk factors: a systematic review and meta-analysis. Br J Nutr 113:1–15CrossRef
39.
Zurück zum Zitat Golan R, Shelef I, Shemesh E et al (2017) Effects of initiating moderate wine intake on abdominal adipose tissue in adults with type 2 diabetes: a 2-year randomized controlled trial. Public Health Nutr 20:549–555CrossRef Golan R, Shelef I, Shemesh E et al (2017) Effects of initiating moderate wine intake on abdominal adipose tissue in adults with type 2 diabetes: a 2-year randomized controlled trial. Public Health Nutr 20:549–555CrossRef
40.
Zurück zum Zitat King DG, Walker M, Campbell MD et al (2018) A small dose of whey protein co-ingested with mixed-macronutrient breakfast and lunch meals improves postprandial glycemia and suppresses appetite in men with type 2 diabetes: a randomized controlled trial. Am J Clin Nutr 107:550–557CrossRef King DG, Walker M, Campbell MD et al (2018) A small dose of whey protein co-ingested with mixed-macronutrient breakfast and lunch meals improves postprandial glycemia and suppresses appetite in men with type 2 diabetes: a randomized controlled trial. Am J Clin Nutr 107:550–557CrossRef
42.
Zurück zum Zitat Abbasi NN, Purslow PP, Tosh SM et al (2016) Oat beta-glucan depresses SGLT1- and GLUT2-mediated glucose transport in intestinal epithelial cells (IEC-6). Nutr Res 36:541–552CrossRef Abbasi NN, Purslow PP, Tosh SM et al (2016) Oat beta-glucan depresses SGLT1- and GLUT2-mediated glucose transport in intestinal epithelial cells (IEC-6). Nutr Res 36:541–552CrossRef
43.
Zurück zum Zitat Carlstrom M, Larsson SC (2018) Coffee consumption and reduced risk of developing type 2 diabetes: a systematic review with meta-analysis. Nutr Rev 76:395–417CrossRef Carlstrom M, Larsson SC (2018) Coffee consumption and reduced risk of developing type 2 diabetes: a systematic review with meta-analysis. Nutr Rev 76:395–417CrossRef
Metadaten
Titel
Ernährung bei Diabetes mellitus Typ 2
verfasst von
Dr. S. Brede
Prof. Dr. H. Lehnert
Publikationsdatum
17.12.2018
Verlag
Springer Medizin
Erschienen in
Die Innere Medizin / Ausgabe 1/2019
Print ISSN: 2731-7080
Elektronische ISSN: 2731-7099
DOI
https://doi.org/10.1007/s00108-018-0531-1

Weitere Artikel der Ausgabe 1/2019

Der Internist 1/2019 Zur Ausgabe

Schwerpunkt: Multiples Myelom

Pathogenese des Multiplen Myeloms

Praxisempfehlungen der Deutschen Diabetes Gesellschaft

Kurz, prägnant und aktuell: Die Praxisempfehlungen der Deutschen Diabetes Gesellschaft.